A Study Of PGN-EDO51 In Participants With Duchenne Muscular Dystrophy Amenable To Exon 51-Skipping Treatment
Clinical trial NCT06079736 · TERMINATED
Trial details
- NCT number
- NCT06079736
- Sponsor
- PepGen Inc
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-01-03
- Primary completion
- 2025-08-28
- Enrollment
- 7
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.